Research and development in electronic and information materials, the environment and energy fields, and new areas
First written in FY2016. 18 of 26 entries say "Restated". Latest entry: FY2026.
1 other company's latest entry also says "Reframed".
- FY2026ReframedAnnual report
「For fine powders, the company is promoting the development of high-performance products tailored to market and customer needs to expand its business areas, in addition to applications in light-diffusing sheets in its core LCD field, including the growing electronic materials and battery-related fields and cosmetic applications.」
The company has broadened its R&D scope from LCD applications to electronic materials, battery-related products and cosmetic applications, repositioning this as an expansion of its business areas through high-performance products. - 2026-05-29AdvancedResults presentation
「ポリエステル・バイオマス・ホットメルト・接着領域での新製品開発・量産技術開発や粉体化技術の先鋭化による新規領域・川下領域への事業展開」
成長分野での研究開発方針を、製品領域、量産技術、粉体化技術、川下展開まで具体化している。 - FY2024-Q2RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The company stated that there had been no material changes in its R&D priorities or structure. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥339 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
The company stated that there had been no material changes in its R&D activities and that it continues to invest in R&D. - FY2023-Q3RestatedAnnual report
「To achieve sustainable growth and enhance corporate value, the Group is working to establish a growth foundation by creating new business opportunities in growth fields such as automotive and information and electronics, and to establish a new-business development structure aimed at solving social issues through collaboration with research institutions and startups in medical healthcare, environmental, and energy fields.」
The company continues to prioritize creating business opportunities in growth sectors and developing solutions to social issues through collaboration with research institutions and startups as its focus for R&D and new businesses. - FY2023-Q1ReframedAnnual report
「To achieve sustainable growth and enhance corporate value, the Group is working to establish a growth foundation by creating new business opportunities in growth fields such as automotive and information and electronics, and to establish a new-business development structure aimed at solving social issues through collaboration with research institutions and startups in medical healthcare, environmental, and energy fields.」
The company has organized its priorities for R&D and new businesses around growth opportunities in the automotive and information electronics sectors and development aimed at addressing social issues through collaboration with research institutions and startups in healthcare, environmental and energy fields. - FY2022RestatedAnnual report
「With regard to R&D investment, the company is placing greater weight on new materials development based on its medium- to long-term business strategy. In addition to leveraging its proprietary technologies and know-how, it is actively pursuing joint research with external research institutions and collaboration with other companies.」
The company continues to prioritize new materials development and pursue joint research with external research institutions and collaboration with other companies. The R&D workforce numbered 140, and R&D expenses were ¥1,455 million. - FY2022-Q1ReframedAnnual report
「The company is working to strengthen product development and sales capabilities in growth areas such as the automotive and information electronics sectors, where technological innovation is advancing, and to develop new businesses in areas such as healthcare and energy aimed at addressing social issues.」
The company has organized its R&D and product development priorities around growth areas in the automotive and information electronics sectors and themes aimed at addressing social issues in healthcare and energy. - FY2021AdvancedAnnual report
「The R&D structure was revised at the beginning of the current fiscal year with the establishment of the Product Development Department to strengthen product development functions for existing businesses. The R&D Center continues to be responsible for strengthening core technologies from a medium- to long-term perspective, developing new functional materials, and conducting technical development of production processes.」
The company established the Product Development Department and outlined its division of responsibilities with the R&D Center. R&D expenses were ¥1,421 million, and the R&D workforce numbered 148. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the first nine months of the fiscal year were ¥1,048 million. There were no material changes in the status of the Group's R&D activities during the period.」
The company disclosed total R&D expenses of ¥1,048 million for the first nine months while stating that there had been no material changes in its R&D activities. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥671 million.」
While stating that there have been no significant changes in the status of its R&D activities, the company disclosed total R&D expenses of ¥671 million for the cumulative second quarter of the current consolidated fiscal year. - FY2021-Q1RestatedAnnual report
「Under these conditions, the Group is thoroughly implementing measures to prevent infection with the novel coronavirus while responding swiftly and flexibly to changes in market and customer needs. To strengthen the earnings base of existing businesses and create new business fields, it is expanding R&D functions and production capacity at its Chinese business bases, promoting cross-organizational strategies focused on synergies among businesses in growth fields such as automotive, energy, and healthcare, and establishing an ongoing new-business development structure that anticipates future changes in the social environment and technological innovation.」
The company continues to expand R&D functions at its Chinese business bases, pursue synergies in growth fields, and maintain a new business development structure that anticipates future changes in the social environment and technological innovation. - FY2020ReframedAnnual report
「The company is directing research investment toward new materials and new business development to achieve medium- to long-term growth, and is actively advancing external collaboration, including cooperation with other companies, rather than relying solely on its proprietary technologies and know-how.」
The company has organized its R&D priorities around new materials and new business development and is advancing external collaboration, including cooperation with other companies, in addition to using its proprietary technologies. Its R&D departments had 147 employees, and R&D expenses were ¥1.468 billion. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥1.046 billion. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company states that there have been no significant changes in the focus of its R&D activities and disclosed R&D expenses of ¥1.046 billion for the cumulative third quarter of the current consolidated fiscal year. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥355 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
While stating that there have been no significant changes in its R&D activities, the company disclosed total first-quarter R&D expenses of ¥355 million. - FY2019ReframedAnnual report
「At the end of the current consolidated fiscal year, the Group's R&D departments, including subsidiaries, had 143 employees, and R&D expenses for the current consolidated fiscal year were ¥1.522 billion. The company focuses its R&D activities on the electronic and information materials, mobility, life sciences and healthcare fields, and is actively working to create new products and services to expand its business domains.」
The company disclosed 143 employees in its R&D departments and R&D expenses of ¥1.522 billion, and has organized its focus areas around mobility, life sciences and healthcare, among others. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥1.137 billion. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company states that there have been no significant changes in its R&D activities and disclosed R&D expenses of ¥1.137 billion for the cumulative third quarter of the current consolidated fiscal year. - FY2019-Q2RestatedAnnual report
「The company is working to strengthen its R&D structure to create new products and services in areas such as automotive and healthcare, where technological innovation is advancing.」
While stating that there have been no significant changes in the status of its R&D activities, the company continues to prioritize the creation of new products and services in areas such as automotive and healthcare. - FY2019-Q1RestatedAnnual report
「The company is working to strengthen its R&D structure to create new products and services in areas such as automotive and healthcare, where technological innovation is advancing.」
The company continues to prioritize the creation of new products and services targeting areas such as automotive and healthcare as part of its efforts to strengthen its R&D structure. R&D expenses were ¥354 million, and it states that there have been no significant changes in the status of its activities. - FY2018RestatedAnnual report
「At the end of the current consolidated fiscal year, the Group's R&D departments, including subsidiaries, had 151 employees, and R&D expenses for the current consolidated fiscal year were ¥1.599 billion. The company focuses its R&D activities on the electronic and information materials and environmental and energy fields, while also actively pursuing the development of new fields such as automotive and life sciences.」
While maintaining its R&D focus areas, the company continues to develop new fields such as automotive and life sciences. Its R&D departments had 151 employees, and R&D expenses were ¥1.599 billion. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥1.163 billion. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
While stating that there have been no significant changes in its R&D activities, the company disclosed total R&D expenses of ¥1.163 billion for the cumulative third quarter of the current consolidated fiscal year. - FY2018-Q2RestatedAnnual report
「The company is working to strengthen its R&D structure to create new products and services for the future.」
While stating that there have been no significant changes in its R&D activities, the company disclosed total R&D expenses of ¥785 million for the cumulative second quarter of the current consolidated fiscal year. - FY2018-Q1RestatedAnnual report
「The company is working to strengthen its R&D structure to create new products and services for the future.」
The company has reaffirmed its policy of strengthening its R&D structure to support the creation of new products and services. R&D expenses were ¥361 million, and it states that there have been no significant changes in the status of its activities. - FY2017RestatedAnnual report
「At the end of the 69th fiscal year, the Group's R&D departments, including subsidiaries, had 151 employees, and R&D expenses for the current consolidated fiscal year were ¥1.690 billion. The company focuses its R&D activities on the electronic and information materials and environmental and energy fields, while also actively pursuing the development of new fields such as life sciences.」
The company has maintained its R&D policy covering electronic and information materials, environmental and energy fields, and new fields, and disclosed 151 employees in its R&D departments and R&D expenses of ¥1.690 billion. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥1.283 billion. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company states that there have been no significant changes in its R&D activities and disclosed R&D expenses of ¥1.283 billion for the current cumulative period. - FY2016First statedAnnual report
「The company focuses its R&D activities on the electronic and information materials and environmental and energy fields, while also actively pursuing the development of new fields such as life sciences.」
The company also disclosed that its R&D departments had 150 employees and that R&D expenses were ¥1.953 billion.